XIAP and non-small cell lung carcinoma: The sensitizing effect of BET inhibition towards pro-apoptotic agents through downregulation of c-FLIP and XIAP led us to explore the combination of JQ1 with pro-apoptotic chemotherapy such as cisplatin, which is frequently used as a single agent to treat NSCLC patients.